Why Pfizer Is Still a Top Stock for 2021

Why Pfizer Is Still a Top Stock for 2021
·5 min read

Pharmaceutical giant Pfizer (NYSE: PFE) has been on a lot of investors' minds over the past 12 months. The company's breakthrough COVID-19 vaccine brought it to the forefront of national attention, and the stock performed nicely in 2020. When the COVID-19 pandemic rocked the world, Pfizer stepped up and delivered.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting